United States Diagnostics & Research news

20:42 30 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

PRLD|Prelude Therapeutics Inc|Price:4.520|Chg%:+0.130

This article provides a comprehensive stock analysis of Prelude Therapeutics Inc (PRLD) by TradingKey, highlighting its healthy fundamentals, significant growth potential, and fair valuation within the Biotechnology & Medical Research industry. It notes high institutional ownership and multiple "Buy" ratings from analysts, with a …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

20:41 30 Jul 2026

PR Newswire Earnings Main company 🇺🇸 United States

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026

Illumina, Inc. announced strong financial results for the second quarter of fiscal year 2026, with revenue reaching $1.16 billion, a 9.5% increase from Q2 2025. The company raised its fiscal year 2026 revenue guidance to $4.60-$4.64 billion and non-GAAP diluted EPS guidance to $5.30-$5.40, …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.5%

20:41 30 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Illumina, Inc. (Nasdaq: ILMN) lifts 2026 outlook after Q2 revenue hits $1.16B

Illumina, Inc. (Nasdaq: ILMN) reported strong Q2 2026 financial results with revenue reaching $1.16 billion, a 9.5% increase from the previous year. This performance led the company to raise its full-year 2026 revenue guidance to $4.60-$4.64 billion and non-GAAP diluted EPS guidance to $5.30-$5.40. …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.5%

20:41 30 Jul 2026

Revelio Labs Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies Number of Employees 2026 | Employee Count & Headcount Data

Adaptive Biotechnologies (NASDAQ: ADPT) had approximately 632 employees worldwide as of March 2026, a decline of 18.7% from 777 employees in 2023. Despite the overall headcount decline, the company is actively hiring, with 53 active job postings in 2026, a 40.9% increase from 2025. …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

20:09 30 Jul 2026

BioSpace Earnings Main company 🇺🇸 United States

Natera to Report its Second Quarter Results on August 6, 2026

Natera, Inc. announced it will release its second-quarter 2026 financial results after market close on August 6, 2026. The company will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) on the same day to discuss the results. Investor and …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%

19:40 30 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Guardant Health earnings on deck after catalyst-rich quarter

Guardant Health (GH) is set to release its Q2 earnings, with analysts anticipating a loss of 76 cents per share on revenues of $314.3 million. The company has experienced significant stock growth recently due to the American Cancer Society endorsing its Shield blood test, …

GH main company

Sharemaestro market context Trend signal active 52 weeks +156.0%

19:40 30 Jul 2026

Market source Earnings Main company 🇺🇸 United States

Icon PLC (ICLR) (Q2 2026) Earnings Call Highlights: Strong Bookings Surge Amid Margin Pressures

Icon PLC reported strong Q2 2026 bookings, with gross business wins up 24% year-over-year and a net book-to-bill ratio of 1.51 times, signaling robust demand. However, the company experienced margin pressures due to elevated pass-through activity and a decline in adjusted gross and EBITDA …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

19:39 30 Jul 2026

Revelio Labs Market update Main company 🇺🇸 United States

Twist Bioscience Number of Employees 2026 | Employee Count & Headcount Data

Twist Bioscience Corp. (TWST) had approximately 1,065 employees worldwide as of March 2026, representing a 5.0% growth from 2023. The company is actively hiring, with 133 job postings in 2026, and its workforce is concentrated in the United States, with a growing presence in …

TWST main company

Sharemaestro market context Trend signal active 52 weeks +314.7%

19:38 30 Jul 2026

TipRanks Earnings Main company 🇺🇸 United States

Revvity, Inc. (0KHE) Q3 2024 Earnings Report - Results, Call & Slides

Revvity, Inc. (0KHE) has released its Q3 2024 earnings report, showing an actual EPS of $1.28, beating the consensus of $1.13 by $0.15. The company also reported actual revenue of $684.05M, surpassing the expected $679.66M, with a YoY revenue growth of 1.98%. Revvity's next …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

19:38 30 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Mettler-Toledo earnings on deck as growth expectations cool

Mettler-Toledo International Inc. is preparing to report its second-quarter results, with analysts expecting earnings of $10.79 per share on revenue of $1.03 billion, reflecting moderating growth expectations. Investors will be observing organic revenue trends, margin performance, and management's outlook for the second half of …

MTD main company

Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4%

19:14 30 Jul 2026

Sharemaestro News Company research Main company 🇺🇸 United States

Quest Diagnostics’ 8.6M-share advance tightens the chase toward its 52-week high

DGX gained 8.2% in the latest week on twice its 13-week volume average, leaving the clinical-lab stock 4.2% below its 52-week high while valuation and reversal risk argue for confirmation.

DGX main company

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

19:11 30 Jul 2026

Investing.com South Africa Deals and strategy Main company 🇺🇸 United States

Tempus AI faces earnings test after $1.5B Personalis deal By Investing.com

Tempus AI is set to report its second-quarter results, facing investor scrutiny following its $1.5 billion acquisition of Personalis Inc. This deal aims to expand Tempus's cancer-monitoring capabilities, but analysts are divided on its strategic rationale and potential impact on Tempus's path to profitability. …

PSNL main company

Sharemaestro market context Trend signal active 52 weeks +190.7%

19:10 30 Jul 2026

Moomoo Market update Main company 🇺🇸 United States

XWELL Inc Company Profile & Introduction

This article provides a company profile and introduction for XWELL Inc.

XWEL main company

Sharemaestro market context Price below Trend Line 52 weeks -12.5% · Next-week setup negative 38.0%

19:08 30 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Labcorp Q2 2026 slides: revenue rises 5.8%, guidance lifted

Labcorp reported strong second-quarter 2026 results, with revenue increasing by 5.8% to $3.73 billion and adjusted operating income growing to $588.7 million. The company also lifted its full-year 2026 guidance for both revenue and adjusted earnings per share, driven by solid performance in both …

LH main company

Sharemaestro market context Trend signal active 52 weeks +15.6%

18:45 30 Jul 2026

www.marketscreener.com Earnings Main company 🇺🇸 United States

Earnings Flash (CSTL) Castle Biosciences Posts Q2 Adjusted EPS -$0.07, vs. FactSet Est of -$0.41

Castle Biosciences (CSTL) reported Q2 adjusted EPS of -$0.07, significantly outperforming FactSet's estimate of -$0.41. The company also posted Q2 revenue of $103.5 Million, surpassing the FactSet estimate of $86.2 Million. This positive earnings flash comes alongside other recent company news, including Health Department …

CSTL main company

Sharemaestro market context Price above Trend Line 52 weeks +42.1%

18:25 30 Jul 2026

MarketWatch Market update Main company 🇺🇸 United States

Illumina Inc. stock outperforms competitors on strong trading day

Illumina Inc. (ILMN) saw its stock rise by 5.27% to $205.09 on Thursday, contributing to its third consecutive day of gains. This performance outpaced the broader market, which also experienced a strong trading day with the S&P 500 Index rising 1.66% and the Dow …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.5%

18:10 30 Jul 2026

Business Wire Regulatory and legal Main company 🇺🇸 United States

GRAL Deadline: Rosen Law Firm Urges GRAIL, Inc. (NASDAQ: GRAL) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm is notifying stockholders of GRAIL, Inc. (NASDAQ: GRAL) about a class action lawsuit for alleged misleading statements made between May 13, 2025, and February 19, 2026. The lawsuit claims GRAIL concealed material adverse facts regarding its NHS-Galleri trial's sufficiency to demonstrate …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

18:09 30 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

SLGL|Sol Gel Technologies Ltd|Price:82.730|Chg%:-2.460

This article provides a comprehensive stock analysis of Sol Gel Technologies Ltd (SLGL), highlighting its strong fundamentals, high growth potential, and current "fairly valued" status. Institutional ownership is noted as very high, and analysts have issued "Buy" ratings with a high price target. While …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

18:07 30 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

Charles River Prepares to Report Q2 Earnings: What's in Store?

Charles River Laboratories International, Inc. (CRL) is set to announce its second-quarter 2026 earnings on August 5th, with analysts forecasting a revenue decline of 5.9% and an EPS decrease of 12.8%. The company’s Research Models and Services (RMS) and Discovery and Safety Assessment (DSA) …

CRL main company

Sharemaestro market context Trend signal active 52 weeks +73.0%

18:03 30 Jul 2026

MarketWatch Market update Main company 🇺🇸 United States

Labcorp Holdings Inc. stock outperforms competitors on strong trading day

Labcorp Holdings Inc. (LH) shares rose 2.73% to $315.53 on Thursday, outperforming the S&P 500 Index and the Dow Jones Industrial Average. The company closed just shy of its 52-week high of $315.77. This strong performance occurred during an overall positive trading session for …

LH main company

Sharemaestro market context Trend signal active 52 weeks +15.6%

17:54 30 Jul 2026

MarketWatch Market update Main company 🇺🇸 United States

IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors

IQVIA Holdings Inc. (IQV) stock fell by 3.95% on Thursday, closing at $237.79. This underperformance occurred despite a generally favorable trading session where the S&P 500 Index and Dow Jones Industrial Average both saw gains. The decline ended a five-day winning streak for IQVIA.

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

17:40 30 Jul 2026

Contract Pharma Market update Main company 🇺🇸 United States

ICON to Deploy Claude AI Across Clinical Trial Lifecycle

ICON plc has partnered with Anthropic to integrate Claude AI across the clinical trial lifecycle, leveraging AI to improve study planning, risk detection, and protocol optimization. This multi-year collaboration aims to accelerate innovation in clinical development by combining ICON's expertise with Anthropic's frontier AI …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

17:14 30 Jul 2026

marketscreener.com Analyst action Main company 🇺🇸 United States

Argus Research Adjusts Quest Diagnostics Price Target to $260 From $225, Maintains Buy Rating

Argus Research has increased its price target for Quest Diagnostics (DGX) to $260 from $225, while reiterating a Buy rating on the stock. This adjustment reflects a positive outlook on the company's future performance. The article also notes other recent analyst adjustments for Quest …

DGX main company

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

17:10 30 Jul 2026

Bitget Market update Main company 🇺🇸 United States

RadNet subsidiary DeepHealth wins FDA clearance for AI-powered breast ultrasound tool

DeepHealth, a RadNet subsidiary, has received FDA 510(k) clearance for its AI-powered breast ultrasound tool designed for lesion detection and characterization. The product boasts high accuracy and improved cancer detection sensitivity, with a commercial rollout beginning immediately in the US. Deployment is planned across …

RDNT main company

Sharemaestro market context Price above Trend Line 52 weeks +8.9% · Next-week setup positive 55.5%

17:10 30 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL) alleging violations of federal securities laws. The lawsuit claims that Grail and its officers made false and misleading statements regarding the likelihood of achieving the primary endpoint in …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

17:09 30 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

First Trust entities disclose 10.1M-share NeoGenomics (NEO) position in 13G

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, disclosing beneficial ownership of 10,113,261 shares of NeoGenomics (NEo), which represents 7.77% of the class. First Trust Advisors L.P. and The Charger Corporation hold shared voting …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

17:07 30 Jul 2026

Yahoo! Finance Canada Deals and strategy Main company 🇺🇸 United States

Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026

Quest Diagnostics (DGX) is propelled by broad testing demand, expanded payer access, advanced diagnostics, and strategic partnerships, supporting revenue growth in 2026. The company's base business benefits from physician, hospital, and consumer channels, while advanced diagnostics in multiple health areas and acquisitions contribute significantly. …

DGX main company LH mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

17:00 30 Jul 2026

Sharemaestro Market Watch Weekly signal Main company 🇺🇸 United States

Guardant Health Inc (GH) pullback contrasts with active weekly trend

The healthcare diagnostics stock weakened over the latest week, but the longer 12-week performance and trend screen leave the setup mixed.

GH main company

Sharemaestro market context Trend signal active 52 weeks +156.0%

16:40 30 Jul 2026

kens5.com Earnings Main company 🇺🇸 United States

Veracyte: Q2 Earnings Snapshot

Veracyte Inc. (VCYT) reported robust second-quarter results, with profits reaching $25.5 million, or 31 cents per share. After adjustments, earnings were 54 cents per share, surpassing Wall Street's expectation of 43 cents. The molecular diagnostic company also exceeded revenue forecasts, posting $150.3 million against …

VCYT main company

Sharemaestro market context Trend signal active 52 weeks +33.1%

16:11 30 Jul 2026

TradingView Market update Main company 🇺🇸 United States

PTA-PVR: QIAGEN N.V.: Veröffentlichung nach § 40 Abs. 1 WpHG

This article announces that QIAGEN N.V. has published a voting rights notification in accordance with § 40 Abs. 1 WpHG, as informed by the AFM on July 29, 2026. The notification details various share and voting rights distributions related to Goldman Sachs Group Inc., …

QGEN main company

Sharemaestro market context Price above Trend Line 52 weeks -14.1%

16:00 30 Jul 2026

Market source Earnings Main company 🇺🇸 United States

Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates

Castle Biosciences, Inc. (CSTL) reported a Q2 loss of $0.07 per share, significantly beating the Zacks Consensus Estimate loss of $0.44 due to non-recurring items. The company also surpassed revenue estimates with $103.55 million, an 18.61% beat, continuing a trend of outperforming revenue expectations …

CSTL main company

Sharemaestro market context Price above Trend Line 52 weeks +42.1%

15:42 30 Jul 2026

MarketScale Deals and strategy Provider-linked mention 🇺🇸 United States

Tempus AI buys Personalis for $1.7B as digital health M&A su

Tempus AI's acquisition of Personalis for $1.7 billion signals a significant consolidation trend in health-tech amid a surge in M&A and venture capital activities, with $7.4 billion in funding during the first half of 2026. This trend is reshaping vendor choices for health system …

PSNL mentioned

Sharemaestro market context Trend signal active 52 weeks +190.7%

15:41 30 Jul 2026

Moomoo Earnings Main company 🇺🇸 United States

Earnings Beat: OPKO Health, Inc. (NASDAQ:OPK) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

OPKO Health, Inc. recently reported a significant earnings beat, surpassing analyst revenue and statutory EPS forecasts. Following these results, analysts have raised their revenue and EPS estimates for the company's future performance, suggesting a more optimistic outlook. The revised forecasts indicate a positive sentiment …

OPK main company

Sharemaestro market context Trend signal active 52 weeks -2.1%

15:41 30 Jul 2026

Investing.com Earnings Provider-linked mention 🇺🇸 United States

Earnings call transcript: Labcorp tops Q2 2026 estimates, lifts full-year outlook

Labcorp exceeded Q2 2026 estimates with strong revenue and adjusted EPS, leading to a lifted full-year outlook. The company reported adjusted EPS of $4.99 and revenue of $3.73 billion, driven by solid organic growth, margin expansion, and strong performance in specialty testing and biopharma …

DGX mentioned LH mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

15:39 30 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies stock hits 52-week high at 23.25 USD

Adaptive Biotechnologies (ADPT) stock reached a 52-week high of $23.25, reflecting a significant 120.31% increase over the past year. Despite its robust revenue growth of 56% over the last twelve months, InvestingPro analytical data suggests the stock might be overvalued. Recent Q2 results showed …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

15:39 30 Jul 2026

Investing.com Market update Main company 🇺🇸 United States

Natera executive chairman sells $447k in shares

Matthew Rabinowitz, Executive Chairman and Director of Natera, Inc. (NASDAQ:NTRA), sold 1,718 shares for $447,523 to cover tax obligations related to restricted stock units. This sale comes as Natera shares have risen 80% over the past year, though InvestingPro suggests the stock is overvalued. …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%